The Center for iPS Cell Research and Application, Kyoto University and Astellas Pharma Inc. entered into the second phase of a joint research agreement to further promote the utilization of differentiated cells and tissues derived from human induced pluripotent stem cells (iPS cells) and to create innovative medical solutions.
PointClickCare Acquires CPSI Subsidiary, American HealthTech
PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of American HealthTech, Inc. (AHT), a subsidiary of Computer Programs and Systems, Inc. and a leading provider of electronic health record (EHR) solutions […]
